• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRCC-TFE3 融合介导的 PRKN/parkin 依赖性线粒体自噬促进 PRCC-TFE3 易位肾细胞癌中的细胞存活和增殖。

PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma.

机构信息

Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing, Jiangsu, China.

Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing, Jiangsu, China.

出版信息

Autophagy. 2021 Sep;17(9):2475-2493. doi: 10.1080/15548627.2020.1831815. Epub 2020 Oct 21.

DOI:10.1080/15548627.2020.1831815
PMID:33019842
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8496718/
Abstract

TFE3 (transcription factor binding to IGHM enhancer 3) nuclear translocation and transcriptional activity has been implicated in PINK1-PRKN/parkin-dependent mitophagy. However, the transcriptional control governing the mitophagy in TFE3/Xp11.2 translocation renal cell carcinoma ( tRCC) is largely unknown. Here, we investigated the role and mechanisms of PRCC-TFE3 fusion protein, one of TFE3 fusion types in TFE3 tRCC, in governing mitophagy to promote development of tRCC. We observed and analyzed mitophagy, transcriptional control of PRCC-TFE3 on PINK1-PRKN-dependent mitophagy, PRCC-TFE3 fusions nuclear translocation, cancer cell survival and proliferation under mitochondrial oxidative damage in tRCC cell line. We found that nuclear-aggregated PRCC-TFE3 fusions constitutively activated expression of the target gene E3 ubiquitin ligase , leading to rapid PINK1-PRKN-dependent mitophagy that promoted cell survival under mitochondrial oxidative damage as well as cell proliferation through decreasing mitochondrial ROS formation. However, nuclear translocation of TFE3 fusions escaped from PINK1-PRKN-dependent mitophagy. Furthermore, we confirmed that PRCC-TFE3 fusion accelerated mitochondrial turnover by activating PPARGC1A/PGC1α-NRF1. In conclusion, our findings indicated a major role of PRCC-TFE3 fusion-mediated mitophagy and mitochondrial biogenesis in promoting proliferation of tRCC.

摘要

TFE3(转录因子结合 IGHM 增强子 3)核易位及其转录活性与 PINK1-PRKN/parkin 依赖性线粒体自噬有关。然而,TFE3/Xp11.2 易位肾细胞癌(tRCC)中调节线粒体自噬的转录控制在很大程度上尚不清楚。在这里,我们研究了 PRCC-TFE3 融合蛋白(TFE3 融合类型之一)在调节线粒体自噬以促进 tRCC 发展中的作用和机制。我们观察和分析了线粒体自噬、PRCC-TFE3 对 PINK1-PRKN 依赖性线粒体自噬的转录控制、PRCC-TFE3 融合核易位、线粒体氧化损伤下 tRCC 细胞系中的癌细胞存活和增殖。我们发现核聚集的 PRCC-TFE3 融合蛋白持续激活靶基因 E3 泛素连接酶的表达,导致快速的 PINK1-PRKN 依赖性线粒体自噬,从而促进线粒体氧化损伤下的细胞存活以及通过减少线粒体 ROS 形成来促进细胞增殖。然而,TFE3 融合核易位逃避了 PINK1-PRKN 依赖性线粒体自噬。此外,我们证实 PRCC-TFE3 融合通过激活 PPARGC1A/PGC1α-NRF1 加速线粒体周转。总之,我们的研究结果表明 PRCC-TFE3 融合介导的线粒体自噬和线粒体生物发生在促进 tRCC 增殖中起主要作用。

相似文献

1
PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma.PRCC-TFE3 融合介导的 PRKN/parkin 依赖性线粒体自噬促进 PRCC-TFE3 易位肾细胞癌中的细胞存活和增殖。
Autophagy. 2021 Sep;17(9):2475-2493. doi: 10.1080/15548627.2020.1831815. Epub 2020 Oct 21.
2
Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma.雄激素受体调控 TFE3 融合蛋白的 SUMOylation 和泛素化是 Xp11.2 易位肾细胞癌治疗的潜在靶点。
Clin Transl Med. 2022 Apr;12(4):e797. doi: 10.1002/ctm2.797.
3
MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.微小 RNA-204-5p:Xp11.2 易位性肾细胞癌的新型候选尿生物标志物。
Cancer Sci. 2019 Jun;110(6):1897-1908. doi: 10.1111/cas.14026. Epub 2019 May 24.
4
PRCC-TFE3 regulates migration and invasion of translocation renal cell carcinomas via activation of Drp1-dependent mitochondrial fission.PRCC-TFE3 通过激活依赖于 Drp1 的线粒体裂变来调节易位性肾细胞癌的迁移和侵袭。
Cell Biol Int. 2020 Aug;44(8):1727-1733. doi: 10.1002/cbin.11366. Epub 2020 May 3.
5
The positive regulation loop between NRF1 and NONO-TFE3 fusion promotes phase separation and aggregation of NONO-TFE3 in NONO-TFE3 tRCC.NRF1 和 NONO-TFE3 融合蛋白之间的正调控环路促进 NONO-TFE3 在 NONO-TFE3 tRCC 中的相分离和聚集。
Int J Biol Macromol. 2021 Apr 15;176:437-447. doi: 10.1016/j.ijbiomac.2021.02.061. Epub 2021 Feb 13.
6
Exploring G-quadruplex structure in PRCC-TFE3 fusion oncogene: Plausible use as anti cancer therapy for translocation Renal cell carcinoma (tRCC).探索 PRCC-TFE3 融合癌基因中的 G-四链体结构:作为治疗易位性肾细胞癌(tRCC)的抗癌疗法的可能性。
J Biotechnol. 2024 Jul 10;390:39-49. doi: 10.1016/j.jbiotec.2024.05.004. Epub 2024 May 11.
7
Nuclear translocation of ASPL-TFE3 fusion protein creates favorable metabolism by mediating autophagy in translocation renal cell carcinoma.核内易位的 ASPL-TFE3 融合蛋白通过介导转位性肾细胞癌中的自噬作用创造有利的代谢。
Oncogene. 2021 May;40(18):3303-3317. doi: 10.1038/s41388-021-01776-8. Epub 2021 Apr 12.
8
Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage.Xp11易位性肾细胞癌的临床异质性:融合亚型、年龄和分期的影响
Mod Pathol. 2014 Jun;27(6):875-86. doi: 10.1038/modpathol.2013.208. Epub 2013 Dec 6.
9
Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agents.表型筛选转移性 PRCC-TFE3 融合易位肾细胞癌类器官揭示潜在的治疗药物。
Clin Transl Oncol. 2022 Jul;24(7):1333-1346. doi: 10.1007/s12094-021-02774-8. Epub 2022 Feb 3.
10
PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.PRCC-TFE3双融合荧光原位杂交检测:一种在石蜡包埋组织中识别PRCC-TFE3肾细胞癌的新方法。
PLoS One. 2017 Sep 26;12(9):e0185337. doi: 10.1371/journal.pone.0185337. eCollection 2017.

引用本文的文献

1
Diagnosis and management of TFE3-rearranged renal cell carcinoma: case report and literature review.TFE3 重排肾细胞癌的诊断与管理:病例报告及文献综述
BMC Urol. 2025 Aug 20;25(1):207. doi: 10.1186/s12894-025-01908-2.
2
Mitophagy related gene signature for prognosis and therapeutic evaluation in KIRC.肾透明细胞癌中用于预后和治疗评估的线粒体自噬相关基因特征
Sci Rep. 2025 Jul 26;15(1):27273. doi: 10.1038/s41598-025-10798-1.
3
Rpl12 is a conserved ribophagy receptor.核糖体蛋白L12是一种保守的核糖体自噬受体。
Nat Cell Biol. 2025 Mar;27(3):477-492. doi: 10.1038/s41556-024-01598-2. Epub 2025 Feb 11.
4
TFE3-mediated neuroprotection: Clearance of aggregated α-synuclein and accumulated mitochondria in the AAV-α-synuclein model of Parkinson's disease.TFE3介导的神经保护作用:在帕金森病腺相关病毒-α-突触核蛋白模型中清除聚集的α-突触核蛋白和积累的线粒体。
Genes Dis. 2024 Sep 7;12(2):101429. doi: 10.1016/j.gendis.2024.101429. eCollection 2025 Mar.
5
Upregulation of GSTP1 mediated by chimeric TFE3 promotes TFE3-tRCC progression by targeting JNK signaling pathway.嵌合型TFE3介导的GSTP1上调通过靶向JNK信号通路促进TFE3相关性肾细胞癌进展。
World J Surg Oncol. 2024 Dec 30;22(1):352. doi: 10.1186/s12957-024-03633-w.
6
TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.肾TFE3重排肿瘤:一个新出现的难题。
Cancers (Basel). 2024 Oct 4;16(19):3396. doi: 10.3390/cancers16193396.
7
PRKN-mediated the ubiquitination of IQGAP3 regulates cell growth, metastasis and ferroptosis in early-onset colorectal cancer.PRKN介导的IQGAP3泛素化调控早发性结直肠癌的细胞生长、转移和铁死亡。
J Bioenerg Biomembr. 2024 Dec;56(6):645-655. doi: 10.1007/s10863-024-10039-6. Epub 2024 Sep 30.
8
Nutritional Supplements for Skin Health-A Review of What Should Be Chosen and Why.营养补充剂对皮肤健康的影响——应选择什么及原因的综述。
Medicina (Kaunas). 2023 Dec 29;60(1):68. doi: 10.3390/medicina60010068.
9
LncRNA like NMRK2 mRNA functions as a key molecular scaffold to enhance mitochondrial respiration of NONO-TFE3 rearranged renal cell carcinoma in an NAD kinase-independent manner.LncRNA 样 NMRK2 mRNA 作为一种关键的分子支架,以 NAD 激酶非依赖的方式增强 NONO-TFE3 重排的肾细胞癌的线粒体呼吸作用。
J Exp Clin Cancer Res. 2023 Sep 28;42(1):252. doi: 10.1186/s13046-023-02837-4.
10
Emerging roles of TFE3 in metabolic regulation.TFE3在代谢调节中的新作用。
Cell Death Discov. 2023 Mar 11;9(1):93. doi: 10.1038/s41420-023-01395-0.

本文引用的文献

1
CDK4/6 regulate lysosome biogenesis through TFEB/TFE3.CDK4/6 通过 TFEB/TFE3 调节溶酶体生物发生。
J Cell Biol. 2020 Aug 3;219(8). doi: 10.1083/jcb.201911036.
2
AUTACs: Cargo-Specific Degraders Using Selective Autophagy.AUTACs:利用选择性自噬的货物特异性降解物。
Mol Cell. 2019 Dec 5;76(5):797-810.e10. doi: 10.1016/j.molcel.2019.09.009. Epub 2019 Oct 9.
3
BAP31 regulates mitochondrial function via interaction with Tom40 within ER-mitochondria contact sites.BAP31 通过与内质网-线粒体接触位点中的 Tom40 相互作用来调节线粒体功能。
Sci Adv. 2019 Jun 12;5(6):eaaw1386. doi: 10.1126/sciadv.aaw1386. eCollection 2019 Jun.
4
Diminished OPA1 expression and impaired mitochondrial morphology and homeostasis in Aprataxin-deficient cells.Aprataxin 缺陷细胞中 OPA1 表达减少和线粒体形态及稳态受损。
Nucleic Acids Res. 2019 May 7;47(8):4086-4110. doi: 10.1093/nar/gkz083.
5
Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy.多前药纳米反应器诱导的线粒体特异性药物释放和活性氧爆发可以增强化疗。
Nat Commun. 2019 Apr 12;10(1):1704. doi: 10.1038/s41467-019-09566-3.
6
TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas.TFE3 融合蛋白逃避了 mTOR 信号通路的调控,并在 Xp11.2 易位肾细胞癌的细胞核中积累,促进基因表达。
J Exp Clin Cancer Res. 2019 Mar 8;38(1):119. doi: 10.1186/s13046-019-1101-7.
7
Targeting mitochondria in cancer: current concepts and immunotherapy approaches.靶向癌症中的线粒体:当前的概念和免疫治疗方法。
Transl Res. 2018 Dec;202:35-51. doi: 10.1016/j.trsl.2018.07.013. Epub 2018 Jul 31.
8
Folliculin Regulates Osteoclastogenesis Through Metabolic Regulation.成纤维细胞调节素通过代谢调节调控破骨细胞生成。
J Bone Miner Res. 2018 Oct;33(10):1785-1798. doi: 10.1002/jbmr.3477. Epub 2018 Jun 26.
9
Mitochondrial metabolism and cancer.线粒体代谢与癌症。
Cell Res. 2018 Mar;28(3):265-280. doi: 10.1038/cr.2017.155. Epub 2017 Dec 8.
10
Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma.小豆蔻明通过抑制鼻咽癌中的NF-κB途径诱导ROS介导的G2/M期阻滞和细胞凋亡。
Cell Death Dis. 2017 Aug 31;8(8):e3024. doi: 10.1038/cddis.2017.407.